| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/24/2011 | CN101822717B Preparation of compound Chinese herbal medicine and its function for promoting growth of cryprinus carpiod |
| 08/24/2011 | CN101780202B Body-fragrant medicament and preparation method thereof |
| 08/24/2011 | CN101773565B Preparation and feeding active function of compound Chinese herbal medicine |
| 08/24/2011 | CN101747446B Method for extracting anti-fatigue acidic ginseng polysaccharide |
| 08/24/2011 | CN101015312B Health care functional tea for conditioning subhealthy state |
| 08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
| 08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
| 08/23/2011 | US8003704 Tryptophan metabolite as aldehyde dehydrogenase inhibitor; side effect reduction |
| 08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 08/23/2011 | US8003645 type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
| 08/23/2011 | US8003101 Inflammatory mediator antagonists |
| 08/23/2011 | US8003092 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 08/23/2011 | CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy |
| 08/23/2011 | CA2504820C Pyrazolonaphthyridine derivatives |
| 08/23/2011 | CA2485494C Anti-tumour polycyclic carboxamides |
| 08/23/2011 | CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 08/23/2011 | CA2449954C Dry powder inhalation system for transpulmonary administration |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/23/2011 | CA2348926C Methods and compositions for the prevention of tolerance to medications |
| 08/23/2011 | CA2335488C Conformationally constrained backbone cyclized somatostatin analogs |
| 08/23/2011 | CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/18/2011 | WO2011099570A1 Age production inhibitor |
| 08/18/2011 | WO2011099514A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
| 08/18/2011 | WO2011099305A1 5-ht4 receptor agonists for the treatment of dementia |
| 08/18/2011 | WO2011098579A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
| 08/18/2011 | US20110201940 Renal Function Analysis Method and Apparatus |
| 08/18/2011 | US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/18/2011 | US20110201673 Lpl variant therapeutics |
| 08/18/2011 | US20110201654 Therapeutic combination |
| 08/18/2011 | US20110201029 Il-13 receptor antibodies |
| 08/18/2011 | US20110200676 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute |
| 08/18/2011 | US20110200642 Compositions and Methods to Promote Implantation and Engrafment of Stem Cells |
| 08/18/2011 | US20110200588 Methods for genetic analysis |
| 08/18/2011 | US20110200577 Biomatrices to attract and retain regenerative and reparative cells |
| 08/18/2011 | US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 08/18/2011 | US20110200531 Treatment and diagnosis of central nervous system disorders |
| 08/18/2011 | CA2789663A1 5-ht4 receptor agonists for the treatment of dementia |
| 08/17/2011 | EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia |
| 08/17/2011 | EP2357182A1 Inhibitors of tyrosine kinases |
| 08/17/2011 | EP2357171A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 08/17/2011 | EP2357165A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357005A1 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 08/17/2011 | EP2355835A1 Use of escin for treatment of type iv hypersensitivity reaction |
| 08/17/2011 | EP2087899B1 Grifola frondosa-derived substance having anti-influenza virus activity and method for producing the same |
| 08/17/2011 | EP1808170B1 Aqueous eye drops with accelerated intraocular migration |
| 08/17/2011 | EP1491553B1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 08/17/2011 | EP1485360B1 Sodium channel blockers |
| 08/17/2011 | EP1474134B1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ramipril for preventing or blocking heart failure |
| 08/17/2011 | EP1444233B1 A2b adenosine receptor antagonists |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 08/17/2011 | EP0853618B1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl -azaheterocyclylamide compounds |
| 08/17/2011 | CN1637416B Labelled growth hormone secretagogue and its synthesis method and uses |
| 08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
| 08/17/2011 | CN102159565A Benzimidazole compound in crystal form and salt thereof |
| 08/17/2011 | CN102159211A Compositions for treatment of fibrotic diseases or conditions |
| 08/17/2011 | CN102153650A Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153649A Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 08/17/2011 | CN102153648A EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 08/17/2011 | CN102153647A Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102151334A Antibody against a tumor-specific antigen as target |
| 08/17/2011 | CN102151273A 2,4,6-triamino-1,3,5-triazine derivative |
| 08/17/2011 | CN102151271A Use of tetrahydrofolates for modulating the homocysteine level |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN101690766B Gentle bath foam traditional Chinese medicine composite, preparation method thereof and application thereof in preparing drugs and health care products to cure cold-type fatigue syndrome and obesity |
| 08/17/2011 | CN101559216B Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof |
| 08/17/2011 | CN101503407B Imidazopyridine compound |
| 08/17/2011 | CN101420931B Solid preparation for oral application |
| 08/17/2011 | CN101348526B Anti-interleukin-8 antibody |
| 08/17/2011 | CN101307052B Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7999101 Genetic material complexing and internalizing capacity; low cytotoxicity; such as 2-[4-(3-amino-propylamino)-6-tetradecylamino-[1,3,5]triazin-2-ylamino]-ethanethiol or its disulphide dimer |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998933 Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 08/16/2011 | CA2614603C Azolo triazines and pyrimidines |
| 08/16/2011 | CA2496731C Novel benzonaphthyridines |
| 08/16/2011 | CA2493423C Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
| 08/16/2011 | CA2485903C Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/16/2011 | CA2480275C Statin therapy for enhancing cognitive maintenance |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |